戻る Agenda
HTA for Medical Devices
Session Chair(s)
Petrus Laestadius
Executive Vice President
Swedish Medtech, Sweden
This session will cover the special features of HTA for medical devices and what the pharmaceutical sector can learn from them. Issues like evidence hierarchies, possibilities to gather, assessing and appraising evidence as well as uncertainty will be discussed. The focus will also be on how to make HTA-based decisions and recommendations for medical devices and how to draw a line between pharmaceuticals and medical devices in the future.
Speaker(s)
The Swedish Joint Project on HTA for Medical Devices
Malin Blixt, LLM
Dental and Pharmaceuticals Benefits Agency (TLV), Sweden
Head of Unit
The Industry Perspective on HTA for Medical Devices
Steffen Kruse, MHS, MS
B. Braun Melsungen AG, Germany
Manager Market Access